Torrent Pharmaceuticals Limited
TORNTPHARM
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 20264,145
Quarter ₹ crore YoY Sept 2024 2,434 +13.4% Dec 2024 2,377 +12.0% Mar 2025 2,433 +13.5% Jun 2025 2,616 +7.3% Sept 2025 2,762 +13.5% Dec 2025 2,599 +9.3% Mar 2026 2,735 +12.4% Jun 2026 4,158 +58.9% Sept 2026 4,145 +50.1% - ₹ crore
Sept 2026-11
Quarter ₹ crore Sept 2024 -7 Dec 2024 3 Mar 2025 15 Jun 2025 -5 Sept 2025 -27 Dec 2025 -8 Mar 2026 58 Jun 2026 -21 Sept 2026 -11 - ₹ crore
Sept 20264,134
Quarter ₹ crore Sept 2024 2,427 Dec 2024 2,380 Mar 2025 2,448 Jun 2025 2,611 Sept 2025 2,735 Dec 2025 2,591 Mar 2026 2,793 Jun 2026 4,137 Sept 2026 4,134 - Cost structure
- ₹ crore
Sept 2026669
Quarter ₹ crore Sept 2024 407 Dec 2024 407 Mar 2025 416 Jun 2025 453 Sept 2025 460 Dec 2025 479 Mar 2026 487 Jun 2026 677 Sept 2026 669 - ₹ crore
Sept 20263,448
Quarter ₹ crore Sept 2024 1,757 Dec 2024 1,729 Mar 2025 1,802 Jun 2025 1,869 Sept 2025 1,916 Dec 2025 1,824 Mar 2026 2,154 Jun 2026 3,453 Sept 2026 3,448 - Exceptional items and tax
- ₹ crore
Sept 2026676
Quarter ₹ crore Sept 2024 670 Dec 2024 651 Mar 2025 622 Jun 2025 742 Sept 2025 806 Dec 2025 757 Mar 2026 592 Jun 2026 663 Sept 2026 676 - ₹ crore
Sept 2026178
Quarter ₹ crore Sept 2024 210 Dec 2024 166 Mar 2025 148 Jun 2025 191 Sept 2025 209 Dec 2025 180 Mar 2026 125 Jun 2026 171 Sept 2026 178 - Profit
- ₹ crore
Sept 2026498
Quarter ₹ crore YoY Sept 2024 460 +40.7% Dec 2024 485 +63.3% Mar 2025 474 +15.6% Jun 2025 551 +17.5% Sept 2025 597 +29.8% Dec 2025 577 +19.0% Mar 2026 467 -1.5% Jun 2026 492 -10.7% Sept 2026 498 -16.6% - Per share
- ₹ per share
Sept 202613.09
Quarter ₹ per share Sept 2024 13.60 Dec 2024 14.33 Mar 2025 14.00 Jun 2025 16.28 Sept 2025 17.64 Dec 2025 17.04 Mar 2026 13.80 Jun 2026 12.94 Sept 2026 13.09 - Leverage
Debt to equity
timesMar 20250.00x
Quarter times Sept 2024 — Dec 2024 — Mar 2025 0.00x Jun 2025 — Sept 2025 — Dec 2025 — Mar 2026 — Jun 2026 — Sept 2026 —
| ₹ crore | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 2,434 | 2,377 | 2,433 | 2,616 | 2,762 | 2,599 | 2,735 | 4,158 | 4,145 | |
| Revenue YoY | +13.4% | +12.0% | +13.5% | +7.3% | +13.5% | +9.3% | +12.4% | +58.9% | +50.1% |
| -7 | 3 | 15 | -5 | -27 | -8 | 58 | -21 | -11 | |
| 2,427 | 2,380 | 2,448 | 2,611 | 2,735 | 2,591 | 2,793 | 4,137 | 4,134 | |
| Cost structure | |||||||||
| 407 | 407 | 416 | 453 | 460 | 479 | 487 | 677 | 669 | |
| 1,757 | 1,729 | 1,802 | 1,869 | 1,916 | 1,824 | 2,154 | 3,453 | 3,448 | |
| Exceptional items and tax | |||||||||
| 670 | 651 | 622 | 742 | 806 | 757 | 592 | 663 | 676 | |
| 210 | 166 | 148 | 191 | 209 | 180 | 125 | 171 | 178 | |
| Profit | |||||||||
| 460 | 485 | 474 | 551 | 597 | 577 | 467 | 492 | 498 | |
| Net profit YoY | +40.7% | +63.3% | +15.6% | +17.5% | +29.8% | +19.0% | -1.5% | -10.7% | -16.6% |
| Per share | |||||||||
| 13.60 | 14.33 | 14.00 | 16.28 | 17.64 | 17.04 | 13.80 | 12.94 | 13.09 | |
| Leverage | |||||||||
| Debt to equity | — | — | 0.00x | — | — | — | — | — | — |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.